Nicholas Salgia
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Renal cell carcinoma treatment 19
- Oncology 21
- Cancer Immunotherapy and Biomarkers 8
- Pancreatic and Hepatic Oncology Research 7
- Co-authors
- Sumanta K. Pal (32 shared papers)Paulo Gustavo Bergerot (12 shared papers)Nazlı Dizman (21 shared papers)Joann Hsu (21 shared papers)Jeffrey M. Trent (5 shared papers)John D. Gillece (4 shared papers)Lauren Reining (3 shared papers)Sarah K. Highlander (5 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Annals of Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Cancer (1 paper)
- Partner nations
- United StatesBrazilGermany
In The Last Decade
Nicholas Salgia
30 papers receiving 361 citations
Peers
Comparison fields: 5 of 56
- Oncology 199
- Pulmonary and Respiratory Medicine 166
- Cancer Research 76
- Biological Psychiatry 10
- Molecular Biology 178
Countries citing papers authored by Nicholas Salgia
This map shows the geographic impact of Nicholas Salgia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Salgia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Salgia more than expected).
Fields of papers citing papers by Nicholas Salgia
This network shows the impact of papers produced by Nicholas Salgia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Salgia. The network helps show where Nicholas Salgia may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas Salgia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 148 | |
| 2 | 2020 | 36 | |
| 3 | 2021 | 28 | |
| 4 | 2020 | 22 | |
| 5 | 2019 | 22 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 16 | |
| 8 | 2020 | 14 | |
| 9 | 2021 | 12 | |
| 10 | 2023 | 6 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 3 | |
| 13 | 2020 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2020 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2015 | 2 | |
| 20 | 2021 | 2 |
About Nicholas Salgia
Nicholas Salgia is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 35 papers that have together received 362 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (19 papers), Cancer Genomics and Diagnostics (10 papers), Renal and related cancers (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (7 papers), Pancreatic and Hepatic Oncology Research (7 papers), Economic and Financial Impacts of Cancer (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Oncology (199 citations), Pulmonary and Respiratory Medicine (166 citations), Cancer Research (76 citations), Biological Psychiatry (10 citations) and Molecular Biology (178 citations). Nicholas Salgia has collaborated with scholars based in United States, Brazil and Germany. Frequent co-authors include Sumanta K. Pal, Paulo Gustavo Bergerot, Nazlı Dizman, Joann Hsu, Jeffrey M. Trent, John D. Gillece, Lauren Reining, Sarah K. Highlander, Manuel Caitano Maia and Megan Folkerts. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Urologic Oncology Seminars and Original Investigations and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.